MD4X Stock Overview
Amundi MDAX UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management SAS.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Amundi MDAX UCITS ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €128.02 |
| 52 Week High | €145.56 |
| 52 Week Low | €118.86 |
| Beta | 0 |
| 1 Month Change | -0.79% |
| 3 Month Change | 1.27% |
| 1 Year Change | -8.57% |
| 3 Year Change | -24.83% |
| 5 Year Change | -8.86% |
| Change since IPO | 23.17% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| MD4X | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | -3.2% | -1.8% | -2.5% |
| 1Y | -8.6% | 17.2% | -0.4% |
Return vs Industry: MD4X underperformed the German Capital Markets industry which returned 17.2% over the past year.
Return vs Market: MD4X underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| MD4X volatility | |
|---|---|
| MD4X Average Weekly Movement | 1.6% |
| Capital Markets Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MD4X has not had significant price volatility in the past 3 months.
Volatility Over Time: MD4X's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | n/a | www.amundietf.fi/en/professional/products/equity/amundi-mdax-ucits-etf-dist/fr0011857234 |
Amundi MDAX UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management SAS. It invests in the public equity markets of Germany. The fund uses derivatives such as swap contracts to invest in the stocks of companies operating across diversified sectors.
Amundi MDAX UCITS ETF Fundamentals Summary
| MD4X fundamental statistics | |
|---|---|
| Market cap | n/a |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MD4X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MD4X income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MD4X perform over the long term?
See historical performance and comparison